1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Harmonizing tau positron emission tomography in Alzheimer's disease: The CenTauR scale and the joint propagation model
Leuzy, A. LU ; Raket, L.L. LU ; Ossenkoppele, R. LU ; Smith, R. LU ; Hansson, O. LU
and Doré, V.
(2024)
In Alzheimer's and Dementia
20(9).
p.5833-5848
- Contribution to journal › Article
-
Mark
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease
Aschenbrenner, Andrew J. ; Hassenstab, J. J. ; Schindler, S. E. ; Janelidze, S. LU ; Hansson, O. LU
; Morris, J. C.
and Grober, E.
(2024)
In Journal of Prevention of Alzheimer's Disease
11(6).
p.1696-1702
- Contribution to journal › Article
-
Mark
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease
- Contribution to journal › Scientific review
-
Mark
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction : The AD-RIDDLE Project
Malzbender, K. ; Barbarino, P. ; Ferrell, P. Barkman ; Bradshaw, A. ; Brookes, A. J. ; Díaz, C. ; van der Flier, W. M. ; Georges, J. ; Hansson, O. LU
and Hartmanis, M.
, et al.
(2024)
In Journal of Prevention of Alzheimer's Disease
11(2).
p.329-338
- Contribution to journal › Article
- 2023
-
Mark
A longitudinal resource for population neuroscience of school-age children and adolescents in China
- Contribution to journal › Article
-
Mark
Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD) : Study Design and Protocol
- Contribution to journal › Article
-
Mark
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
Mallinckrodt, C. ; Tian, Y. ; Aisen, P. S. ; Barkhof, F. ; Cohen, S. ; Dent, G. ; Hansson, O. LU
; Harrison, K.
; Iwatsubo, T.
and Mummery, C. J.
, et al.
(2023)
In Journal of Prevention of Alzheimer's Disease
10.
p.171-177
- Contribution to journal › Article
- 2022
-
Mark
Brain charts for the human lifespan
Bethlehem, R.A.I. ; Hansson, O. LU
; Ossenkoppele, R.
LU
and Alexander-Bloch, A. F.
(2022)
In Nature
604(7906).
p.525-533
- Contribution to journal › Article
-
Mark
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
Budd Haeberlein, Samantha ; Aisen, P. S. ; Barkhof, F. ; Chalkias, S. ; Chen, T. ; Cohen, S. ; Dent, G. ; Hansson, O. LU
; Harrison, K.
and von Hehn, C.
, et al.
(2022)
In Journal of Prevention of Alzheimer's Disease
9(2).
p.197-210
- Contribution to journal › Article
- 2021
-
Mark
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
Wolters, E. E. ; Dodich, A. ; Boccardi, M. ; Corre, J. ; Drzezga, A. ; Hansson, O. LU
; Nordberg, A.
; Frisoni, G. B.
; Garibotto, V.
and Ossenkoppele, R.
LU
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2097-2109
- Contribution to journal › Scientific review